These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Current acquisitions in diuresis and diuretic therapy]. Varese LA Minerva Pediatr; 1970 Oct; 22(41):1985-96. PubMed ID: 4924425 [No Abstract] [Full Text] [Related]
45. Mechanisms and management of diuretic resistance in congestive heart failure. De Bruyne LK Postgrad Med J; 2003 May; 79(931):268-71. PubMed ID: 12782772 [TBL] [Abstract][Full Text] [Related]
46. Edema formation in congestive heart failure and the underlying mechanisms. Abassi Z; Khoury EE; Karram T; Aronson D Front Cardiovasc Med; 2022; 9():933215. PubMed ID: 36237903 [TBL] [Abstract][Full Text] [Related]
47. Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. Hasenfuss G; Holubarsch C; Herzog C; Knauf H; Spahn H; Mutschler E; Just H Clin Cardiol; 1987 Feb; 10(2):83-8. PubMed ID: 3815928 [TBL] [Abstract][Full Text] [Related]
48. Body fluid volume regulation in health and disease. Abraham WT; Schrier RW Adv Intern Med; 1994; 39():23-47. PubMed ID: 8140955 [TBL] [Abstract][Full Text] [Related]
49. Diuretic Resistance in Cardio-Nephrology: Role of Pharmacokinetics, Hypochloremia, and Kidney Remodeling. Masella C; Viggiano D; Molfino I; Zacchia M; Capolongo G; Anastasio P; Simeoni M Kidney Blood Press Res; 2019; 44(5):915-927. PubMed ID: 31437845 [TBL] [Abstract][Full Text] [Related]
50. Diuretic drug therapy of edema. Perez-Stable EC; Materson BJ Med Clin North Am; 1971 Mar; 55(2):359-72. PubMed ID: 4926056 [No Abstract] [Full Text] [Related]
54. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782 [TBL] [Abstract][Full Text] [Related]
55. [Pharmacological Properties of Loop Diuretics and Their Clinical Effects]. Sakalauskienė G; Civinskienė G; Antuševas A; Civinskas P Kardiologiia; 2018 Jan; (1):72-83. PubMed ID: 29466174 [TBL] [Abstract][Full Text] [Related]
56. [Optimization of diuretic therapy in heart failure]. Knauf H; Hasenfuss G; Just HJ Verh Dtsch Ges Inn Med; 1985; 91():155-67. PubMed ID: 4090614 [No Abstract] [Full Text] [Related]
57. The rational use of diuretics in heart failure. Ravnan SL; Deedwania PC Curr Cardiol Rep; 2003 May; 5(3):237-42. PubMed ID: 12691643 [TBL] [Abstract][Full Text] [Related]
58. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. ter Maaten JM; Valente MA; Damman K; Hillege HL; Navis G; Voors AA Nat Rev Cardiol; 2015 Mar; 12(3):184-92. PubMed ID: 25560378 [TBL] [Abstract][Full Text] [Related]
59. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease]. Alcázar Arroyo R Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744 [TBL] [Abstract][Full Text] [Related]
60. [Progress in management for heart failure: diuretics]. Aoyagi T; Hirata Y Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]